Segment Disclosures - Summary Information for the Reportable Segments (Details) $ in Thousands	1 Months Ended	3 Months Ended
	Jan. 31, 2022 USD ($)	Mar. 31, 2022 USD ($) property	Mar. 31, 2021 USD ($)
Segment Disclosure
Number of facilities owned by unconsolidated joint venture | property		19
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		$ 498,372	$ 455,276
Government grant income		6,552	1,310
Less: Interest income		(5,494)	(9,013)
Healthpeak’s share of unconsolidated joint venture total revenues		20,208	23,293
Healthpeak’s share of unconsolidated joint venture government grant income		648	426
Noncontrolling interests’ share of consolidated joint venture total revenues		(8,877)	(8,991)
Operating expenses		(207,247)	(181,761)
Healthpeak’s share of unconsolidated joint venture operating expenses		(14,837)	(18,059)
Noncontrolling interests’ share of consolidated joint venture operating expenses		2,621	2,524
Adjustments to NOI		(17,666)	(13,601)
Adjusted NOI		274,280	251,404
Plus: Adjustments to NOI		17,666	13,601
Interest income		5,494	9,013
Interest expense		(37,586)	(46,843)
Depreciation and amortization		(177,733)	(157,538)
General and administrative		(23,831)	(24,902)
Transaction costs		(296)	(798)
Impairments and loan loss reserves		(132)	(3,242)
Gain (loss) on sales of real estate, net		3,856	0
Gain (loss) on debt extinguishments		0	(164,292)
Other income (expense), net		18,316	2,200
Less: Government grant income		(6,552)	(1,310)
Less: Healthpeak’s share of unconsolidated joint venture NOI		(6,019)	(5,660)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		6,256	6,467
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		73,719	(121,900)
Income tax benefit (expense)		(777)	(8)
Equity income (loss) from unconsolidated joint ventures		2,084	1,323
Income (loss) from continuing operations		75,026	(120,585)
Income (loss) from discontinued operations		317	270,008
Net income (loss)		75,343	149,423
Corporate Non-segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		0	0
Government grant income		0	0
Less: Interest income		0	0
Healthpeak’s share of unconsolidated joint venture total revenues		0	0
Healthpeak’s share of unconsolidated joint venture government grant income		0	0
Noncontrolling interests’ share of consolidated joint venture total revenues		0	0
Operating expenses		0	0
Healthpeak’s share of unconsolidated joint venture operating expenses		0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses		0	0
Adjustments to NOI		0	0
Adjusted NOI		0	0
Plus: Adjustments to NOI		0	0
Interest income		0	0
Interest expense		(34,685)	(44,728)
Depreciation and amortization		0	0
General and administrative		(23,831)	(24,902)
Transaction costs		0	0
Impairments and loan loss reserves		0	0
Gain (loss) on sales of real estate, net		0
Gain (loss) on debt extinguishments			(164,292)
Other income (expense), net		909	1,817
Less: Government grant income		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		0	0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		(57,607)	(232,105)
Income tax benefit (expense)		(777)	(8)
Equity income (loss) from unconsolidated joint ventures		0	0
Income (loss) from continuing operations		(58,384)	(232,113)
Income (loss) from discontinued operations		317	270,008
Net income (loss)		(58,067)	37,895
Life Science
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net	$ 4,000
Life Science | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		194,055	169,934
Government grant income		0	0
Less: Interest income		0	0
Healthpeak’s share of unconsolidated joint venture total revenues		1,431	1,337
Healthpeak’s share of unconsolidated joint venture government grant income		0	0
Noncontrolling interests’ share of consolidated joint venture total revenues		(57)	(65)
Operating expenses		(48,189)	(39,461)
Healthpeak’s share of unconsolidated joint venture operating expenses		(483)	(425)
Noncontrolling interests’ share of consolidated joint venture operating expenses		19	20
Adjustments to NOI		(14,112)	(11,810)
Adjusted NOI		132,664	119,530
Plus: Adjustments to NOI		14,112	11,810
Interest income		0	0
Interest expense		0	(102)
Depreciation and amortization		(78,138)	(68,434)
General and administrative		0	0
Transaction costs		(292)	(32)
Impairments and loan loss reserves		0	0
Gain (loss) on sales of real estate, net		3,856
Gain (loss) on debt extinguishments			0
Other income (expense), net		(9)	4
Less: Government grant income		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		(948)	(912)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		38	45
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		71,283	61,909
Income tax benefit (expense)		0	0
Equity income (loss) from unconsolidated joint ventures		966	(93)
Income (loss) from continuing operations		72,249	61,816
Income (loss) from discontinued operations		0	0
Net income (loss)		72,249	61,816
Medical Office | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		177,263	160,201
Government grant income		0	0
Less: Interest income		0	0
Healthpeak’s share of unconsolidated joint venture total revenues		732	715
Healthpeak’s share of unconsolidated joint venture government grant income		0	0
Noncontrolling interests’ share of consolidated joint venture total revenues		(8,820)	(8,926)
Operating expenses		(61,170)	(51,121)
Healthpeak’s share of unconsolidated joint venture operating expenses		(299)	(294)
Noncontrolling interests’ share of consolidated joint venture operating expenses		2,602	2,504
Adjustments to NOI		(3,546)	(1,923)
Adjusted NOI		106,762	101,156
Plus: Adjustments to NOI		3,546	1,923
Interest income		0	0
Interest expense		(1,036)	(95)
Depreciation and amortization		(67,773)	(57,954)
General and administrative		0	0
Transaction costs		(4)	(330)
Impairments and loan loss reserves		0	0
Gain (loss) on sales of real estate, net		0
Gain (loss) on debt extinguishments			0
Other income (expense), net		10,937	(2,279)
Less: Government grant income		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		(433)	(421)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		6,218	6,422
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		58,217	48,422
Income tax benefit (expense)		0	0
Equity income (loss) from unconsolidated joint ventures		200	192
Income (loss) from continuing operations		58,417	48,614
Income (loss) from discontinued operations		0	0
Net income (loss)		58,417	48,614
CCRC | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		121,560	116,128
Government grant income		6,552	1,310
Less: Interest income		0	0
Healthpeak’s share of unconsolidated joint venture total revenues		0	4,488
Healthpeak’s share of unconsolidated joint venture government grant income		333	199
Noncontrolling interests’ share of consolidated joint venture total revenues		0	0
Operating expenses		(97,888)	(91,179)
Healthpeak’s share of unconsolidated joint venture operating expenses		0	(4,745)
Noncontrolling interests’ share of consolidated joint venture operating expenses		0	0
Adjustments to NOI		0	20
Adjusted NOI		30,557	26,221
Plus: Adjustments to NOI		0	(20)
Interest income		0	0
Interest expense		(1,865)	(1,918)
Depreciation and amortization		(31,822)	(31,150)
General and administrative		0	0
Transaction costs		0	(432)
Impairments and loan loss reserves		0	0
Gain (loss) on sales of real estate, net		0
Gain (loss) on debt extinguishments			0
Other income (expense), net		6,511	2,176
Less: Government grant income		(6,552)	(1,310)
Less: Healthpeak’s share of unconsolidated joint venture NOI		(333)	58
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		(3,504)	(6,375)
Income tax benefit (expense)		0	0
Equity income (loss) from unconsolidated joint ventures		539	0
Income (loss) from continuing operations		(2,965)	(6,375)
Income (loss) from discontinued operations		0	0
Net income (loss)		(2,965)	(6,375)
Other Non-reportable | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		5,494	9,013
Government grant income		0	0
Less: Interest income		(5,494)	(9,013)
Healthpeak’s share of unconsolidated joint venture total revenues		18,045	16,753
Healthpeak’s share of unconsolidated joint venture government grant income		315	227
Noncontrolling interests’ share of consolidated joint venture total revenues		0	0
Operating expenses		0	0
Healthpeak’s share of unconsolidated joint venture operating expenses		(14,055)	(12,595)
Noncontrolling interests’ share of consolidated joint venture operating expenses		0	0
Adjustments to NOI		(8)	112
Adjusted NOI		4,297	4,497
Plus: Adjustments to NOI		8	(112)
Interest income		5,494	9,013
Interest expense		0	0
Depreciation and amortization		0	0
General and administrative		0	0
Transaction costs		0	(4)
Impairments and loan loss reserves		(132)	(3,242)
Gain (loss) on sales of real estate, net		0
Gain (loss) on debt extinguishments			0
Other income (expense), net		(32)	482
Less: Government grant income		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		(4,305)	(4,385)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		5,330	6,249
Income tax benefit (expense)		0	0
Equity income (loss) from unconsolidated joint ventures		379	1,224
Income (loss) from continuing operations		5,709	7,473
Income (loss) from discontinued operations		0	0
Net income (loss)		$ 5,709	$ 7,473